HCV Patients May Be Able to Delay Therapy - MedPage Today
HCV Patients May Be Able to Delay TherapyMedPage TodayThe addition of new protease inhibitors telaprevir (Incivek) and boceprevir (Victrelis) to previous standard therapy of interferon and ribavirin have significantly boosted sustained viral response for many patients, especially for blacks and Latinos, .
New research reveals effective treatments for gastrointestinal conditions - News-Medical.net
New research reveals effective treatments for gastrointestinal conditionsNews-Medical.
GS-7977 with interferon/ribavirin cures most treatment-naive hepatitis C ... - aidsmap
GS-7977 with interferon/ribavirin cures most treatment-naive hepatitis C .
MEDIVIR AB : Medivir: Interim Report, 1 January - 31 March 2012 - 4-traders
MEDIVIR AB : Medivir: Interim Report, 1 January - 31 March 20124-tradersApart from interferon and ribavirin-free combination trials on TMC435 in phase II, this collaboration now also covers a phase III program Medivir opened 2012 with continued stable sales of Rx pharmaceuticals.
Experts Discuss DAAs for Difficult-To-Treat Hep C Patients - Infectious Disease Special Edition
Infectious Disease Special EditionExperts Discuss DAAs for Difficult-To-Treat Hep C PatientsInfectious Disease Special EditionOverall, the new reports revealed the following: Cirrhotic patients who previously received the standard two-drug therapy and then received telaprevir in combination with pegylated interferon (Peg-IFN) and ribavirin had improved SVR compared with .